The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know.
Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.
Ajanta Pharma ties up with Biocon to target emerging markets for generic weight loss drug
Ajanta Pharma plans to sell generic semaglutide in 26 countries, in a partnership with Biocon, capitalizing on patent expirations. With a strong foothold in emerging markets and a potential 10x market growth, Ajanta aims to become a leading player in the global GLP-1 market by 2027.
US regulator approves Wegovy weight-loss pill
US regulators approved a pill form of the obesity drug Wegovy. The injectable forms have revolutionized weight loss treatment since 2021: Patients lose on average over 15% of their body mass, compared to 2% for prescribed diet and exercise. The rise of GLP-1 drugs is credited with ending the hitherto relentless rise of US obesity […]
“Much-Needed Win”: Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill
“Much-Needed Win”: Novo Shares Jump Most In Nearly Two Years After US Approval Of Wegovy Obesity Pill Novo Nordisk shares in Europe jumped the most in nearly two years after the U.S. FDA approved the Wegovy pill, a once-daily 25 mg oral semaglutide, for long-term weight loss, weight maintenance, and reduction of major adverse cardiovascular […]
U.S. regulators approve Wegovy pill for weight loss – NPR
U.S. regulators approve Wegovy pill for weight loss NPR Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk CNBC F.D.A. Approves Wegovy Weight-Loss Pill The New York Times With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN Explainer-What Novo Nordisk’s weight-loss pill […]
Breaking: Novo Nordisk A/S (NVO) Set For 80% Breakout
Breaking: Novo Nordisk A/S (NVO) Set For 80% Breakout Novo Nordisk A/S Sponsored ADR Class B BATS:NVO DEXWireNews Shares in Novo Nordisk surged over 7% Tuesday premarket after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the […]
Pill Version of Weight-Loss Drug Wegovy Approved by US Regulator
U.S. regulators have green-lit a pill version of the weight-loss drug Wegovy, making an oral version of the so-called “skinny jabs” available for the first time. The Food and Drug Administration approved the pill made by Scandinavian pharmaceutical company Novo Nordisk, giving it the edge over American rival Eli Lilly in the race to bring […]
The Next Ozempic Is Already Being Sold Underground
After Katie started on Ozempic, she got her hairdresser interested, too. This summer, when they saw each other again, she thought that her hairdresser had lost some weight and that she looked “so great.” “Are you still on a GLP-1?” she asked, referring to the class of blockbuster drugs that includes Ozempic and obesity meds. […]
FDA approves Wegovy weight loss pill, paving way for new GLP-1 frontier | Morning in America
The Food and Drug Administration has approved Novo Nordisk’s pill version of its Wegovy medication, a first for GLP-1 weight loss drugs. NewsNation’s Xavier Walton has the details. #Wegovy #GLP1 #Health Start your day with “Morning in America,” NewsNation’s live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is […]
FDA approves first GLP-1 weight loss pill from Novo Nordisk
Dec 23, 2025: 4:59 a.m.: FDA approves first GLP-1 weight loss pill from Novo Nordisk The FDA has approved the first GLP-1 pill for weight loss, clearing a tablet from Novo Nordisk https://t.co/bpAHrjETVT — The Wall Street Journal (@WSJ) December 23, 2025